Ariprex 50ML Oral Solution

Overview

Ariprex Oral Solution contains Aripiprazole, manufactured by Square Pharmaceuticals PLC. It is an atypical antipsychotic used for the treatment of schizophrenia, bipolar I disorder, and as an adjunctive therapy for major depressive disorder, suitable for patients who have difficulty swallowing tablets.

Dosage and Administration

Dosing is equivalent to the tablet formulation on a milligram-for-milligram basis. Typical adult dose ranges from 2 mg to 30 mg once daily depending on the indication, as advised by the physician using the provided measuring device.

Interaction

CYP3A4 inhibitors and CYP2D6 inhibitors may increase aripiprazole levels, requiring dose adjustment. CYP3A4 inducers may decrease its effectiveness.

Contraindications

Contraindicated in patients with known hypersensitivity to aripiprazole.

Side Effects

Akathisia, headache, insomnia, anxiety, and nausea. Weight gain and metabolic changes may occur with long-term use.

Pregnancy and Lactation

Use during pregnancy only if benefits outweigh risks. Caution advised during breastfeeding.

Precautions and Warnings

Increased risk of mortality in elderly patients with dementia-related psychosis. Monitor for suicidal ideation and metabolic changes during treatment. Use the supplied dosing device for accurate measurement.

Storage Conditions

Store below 30°C, protected from light. Do not freeze. Keep out of the reach of children.

Frequently Asked Questions

Who is the oral solution suitable for?
It is suitable for patients who cannot swallow tablets, including some elderly or paediatric patients, under medical guidance.

How should the dose be measured?
Always use the measuring device provided with the medicine to ensure accurate dosing.

This content is for informational purposes only and does not substitute professional medical advice. Please consult a registered physician before taking any medication.